Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K‐ras status for unresectable colorectal liver metastasis (BECK study)
Year: 2015
Type: article
Study design: Clinical Trial
DOI: 10.1002/jhbp.254
Authors: Etsuro Hatano, Masayuki Okuno, Kojiro Nakamura, Takamichi Ishii, Satoru Seo, Kojiro Taura, Kentaro Yasuchika, Takefumi Yazawa, Masazumi Zaima, Akiyoshi Kanazawa, Hiroaki Terajima, Satoshi Kaihara, Yukihito Adachi, Naoya Inoue, Katsuyoshi Furumoto, Dai Manaka, Atsuo Tokka, Hiroaki Furuyama, Koji Doi, Tetsuro Hirose, Takahiro Horimatsu, Suguru Hasegawa, Shigemi Matsumoto, Yoshiharu Sakai, Shinji Uemoto
Institutions: Kyoto University, Shiga Medical Center for Adults, Osaka Red Cross Hospital, Kitano Hospital, Kobe Medical Center, Kobe City Medical Center General Hospital, Saiseikai Noe Hospital, Kansai Electric Power (Japan), Kansai Electric Power Hospital, Kishiwada City Hospital, Kyoto Katsura Hospital, Shimane Prefectural Central Hospital, Tenri Hospital, Fukui Red Cross Hospital, Takamatsu Red Cross Hospital, Kyoto University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1976414596